---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-050002"
form_type: "8-K"
ticker: "ADMA"
cik: "0001368514"
company_name: "ADMA BIOLOGICS, INC."
filed_at: "2024-12-20T23:59:59+00:00"
generated_at: "2026-05-29T00:11:31.216273+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# ADMA Biologics repays $30M of senior secured term loan, total debt reduced to $75M

## Summary
- Repaid $30M of original $62.5M term loan with Ares Capital using cash on hand.
- Total gross debt now $75M: $42.5M revolver plus $32.5M term loan outstanding.
- This is second paydown in four months; total gross debt reduced by 29%.
- Lowered interest expense expected to enhance near-term earnings growth potential.
- CEO cites confidence in sustained earnings growth and ongoing cash generation.

## SEC filing metadata
- accession: 0001140361-24-050002
- form_type: 8-K
- ticker: ADMA
- cik: 0001368514
- company_name: ADMA BIOLOGICS, INC.
- filed_at: 2024-12-20T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1368514/000114036124050002/0001140361-24-050002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1368514/000114036124050002/ef20040424_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-050002
- JSON: https://secwatch.observer/filing/0001140361-24-050002.json
- Plain text: https://secwatch.observer/filing/0001140361-24-050002.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.